Skip to content

News archive

Last pitch of the year was done yesterday our CEO Dorte X. Gram at Redeye
Please, find the link to the video (in Swedish) here
(17-December-2021)
Earlier today, our CEO Dorte X. Gram was interviewed by Aktier.
We thank for the invitation and many good questions!
Please, find interview in Swedish (start at time 4:19) here
(10-December-2021)
Please, check out this PILA PHARMA ’hisspitch’ that Aktiespararna made last week when our CEO Dorte X. Gram was in Stockholm.
Please, find the link to the video (in English) here
(10-December-2021)
Dr. Julius, yesterday, gave his Nobel prize lecture on the discovery of ’the chili receptor’ TRPV1 and its role in thermo-sensation and pain. Our diabetes drug candidate is a TRPV1-antagonist.
Please, find the link to the video (in English) here
(08-December-2021)
In case you missed it, our CEO’s presentation from today’s event at Aktiespararna is now online
Please, find the link to our CEOs presentation (in English) here
(02-December-2021)
Tomorrow, December 2nd at 11:30 AM, our CEO Dorte X. Gram will be presenting at Aktiespararnas “Stora Aktiedagen” in Stockholm, and, give an update on #PILA PHARMA.
It’s possible to text your questions to +46 (0)79-347 98 45 or email to event@aktiespararna.se for the moderator will handle the questions during the Q&A.
You can follow the live stream here (in English) here
(01-December-2021)
We’re delighted to announce that we have signed an agreement with ERBC (European Research Biology Center) on the conduct of our planned preclinical safety studies.
We look forward to the collaboration and, even more so, the results!
Read the full article (in English) here

Läs hela artikeln (in Swedish) här

(01-December-2021)
Last Sunday, Politiken, had an appendix on Diabetes and we appeared on the cover and in a nice article on p. 8-9
Read the article (in Danish) here
(23-November-2021)
We participated in the Redeye Life Science Day 2021 on Thursday last week
Please, find the link to our CEOs presentation (in English) here
(19-November-2021)
FYI our CEO increased the stock holding in PILA earlier this week. Biostock commented on the transaction
You can read it in English here
You can read it in Swedish here
(19-November-2021)
Politiken Pila Pharma
Our CEO was on the cover(again) in one of Politikens appendices on Life Sciences published last Friday
Read the article (in Danish) here
(19-November-2021)
We’re pleased to share our CEOs presentation (in Danish) last week
Thank you to Økonomisk Ugebrev Lifescience for inviting us!
Watch the video in (in Danish) here
(19-November-2021)
We’re pleased to share that our CEO Dorte X. Gram will present PILA PHARMA in Stockholm on Thursday 11 November at 16:30 at the Redeye Lifescience day 2021!
you’re invited to join! Sing up via the link here
(05-November-2021)
Biostock has written an update on us after our Q3 report release
You can read it in English here
(05-November-2021)
Save the date (10 Nov 2021): our CEO Dorte X. Gram will be presenting in Copenhagen, Denmark
you’re invited to join! Sing up via the link here
(02-November-2021)

Delårsrapport 1 juli – 30 september 2021

Läs läs rapporten PDF (in Swedish) här

(26-October-2021)

Yesterday, our CEO Dorte X. Gram presented our company at Aktiespararna.

Please find a link to the presentation here

(29-September-2021)
BioStock

BioStocks: “Pila Pharma takes final steps before toxicology studies”
Read the full article (in English) here

BioStocks: “Pila Pharma tar sista stegen innan toxikologiska studier”
Läs hela artikeln (in Swedish) här

(22-September-2021)
Life Science

Our COO, Lars Bukhave Rasmussen (and possibly som other PILAs), will be attending “The Future of Swedish & Danish Life Science” meeting in Lund, Sweden September 2nd 2021.

Read more (in English) here

(26-August-2021)

Contact us

PilaPharma
Back To Top